Evaluation of Gingival Alterations in Rats Medicated with Cyclosporine A, Tacrolimus and Sirolimus: a Stereological Study

Abstract

Background and ObjectiveIt has previously been shown that both cyclosporine A and tacrolimus cause gingival overgrowth in the rat. We proposed that sirolimus may play an important role in decreasing the severity of gingival overgrowth. Therefore, the aim of this study was to evaluate the gingival changes induced by immunosuppressants, in the presence and absence of sirolimus, using histopathology and stereological methods. Material and MethodsThirty-six male Sprague-Dawley rats were distributed into six treatment groups, each containing six rats, as follows: (i) cyclosporine A for 8wk; (ii) tacrolimus for 8wk; (iii) sirolimus for 8wk; (iv) cyclosporine A+sirolimus for 8wk; (v) tacrolimus+sirolimus for 8wk; and (vi) distilled water for 8wk. Histomorphometric analyses included measurements of epithelial thickness and connective tissue width and height. Stereological analyses included measurements of volumetric densities of fibroblasts (V-f), collagen fibers (V-cf) and blood vessels (V-bv). ResultsConnective tissue width and height were significantly increased in cyclosporine A, tacrolimus and cyclosporine A+sirolimus groups compared with the control group (p<0.05), and epithelial thickness was significantly increased in the cyclosporine A group and tacrolimus group compared with the control group (p<0.05). V-f was significantly increased in the cyclosporine A group and the tacrolimus group compared with the control group (p<0.05), whereas V-cf and V-bv were significantly increased in the cyclosporine A, tacrolimus and cyclosporine A+sirolimus groups compared with the control group (p<0.05). ConclusionThe results of the study suggest that sirolimus seems not to be associated with gingival overgrowth, and combined usage of sirolimus and immunosuppressants decreases the severity of gingival overgrowth.